FDA Extends Continuous Marketing Application Pilot 2 Deadline Again
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
FDA extends continuous marketing application Pilot 2 deadline again. At least eight CDER divisions have chosen INDs for the fast-track pilot program, with eight remaining. Applications will be accepted until Dec. 31